Cefdinir Production Cost Reports

The report provides a detailed analysis essential for establishing a cefdinir production plant. It encompasses all critical aspects necessary for cefdinir production, including the cost of cefdinir production, cefdinir plant cost, cefdinir production costs, and the overall cefdinir production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a cefdinir production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Cefdinir is a widely used oral antibiotic medicine that belongs to the cephalosporin group and is mainly used in the treatment of bacterial infections. It is commonly prescribed for infections of the respiratory tract, including conditions such as bronchitis, sinus infections, and pneumonia. It is also used to treat throat infections like tonsillitis and pharyngitis, as well as ear infections, especially in children. In addition, it also helps in managing certain skin and soft tissue infections caused by harmful bacteria. It works by interfering with the bacteria’s ability to build their cell walls, which helps stop the infection from spreading. It is often chosen as a convenient option because it is available in both capsule and liquid forms, which makes it easier for children and adults to take. Moreover, it is also used in hospitals and clinical settings as part of routine antibiotic therapy for mild to moderate infections. It is frequently used in outpatient treatment settings due to its broad activity against various bacteria.

The market for cefdinir is mainly driven by its application as an oral antibacterial drug to treat mild to moderate bacterial infections, which supports its demand in the medical and healthcare sectors. Its application as a drug for the treatment of respiratory tract infections, otitis media, skin infections, and streptococcal pharyngitis further drives its demand in the pharmaceutical industry. Its demand in the healthcare sector, due to its effectiveness and ease of oral administration, significantly drives its market growth.

Its usage as an important antibiotic to support the treatment of common bacterial diseases and improve patient recovery also contributes to its demand in the healthcare and pharmaceutical industries. Additionally, industrial cefdinir procurement is influenced by factors such as raw material sourcing, pricing of intermediates like 7-ACA (7-aminocephalosporanic acid), quality standards, and regulatory approvals. Advancements in formulation technologies, reliable contract production, and strong distribution networks also play a crucial role in shaping the global cefdinir supply chain.

Raw Material for Cefdinir Production

According to the cefdinir production plant project report, the major raw materials for cefdinir production include 7-amino-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 4-methoxyphenyl ester, 4-Bromoacetyl bromide, sodium nitrite, thiourea, and trifluoroacetic acid.

Production Process of Cefdinir

The extensive cefdinir production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of cefdinir begins with the reaction of 7-amino-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 4-methoxyphenyl ester with 4-bromoacetyl bromide, which introduces a bromoacyl group. This intermediate contains an active methylene group that is further treated with sodium nitrite to generate a nitroso compound, which quickly rearranges into its more stable oxime form. Further, the resulting oxime derivative undergoes transformation upon reaction with thiourea, which introduces a thiazole ring, followed by treatment with trifluoroacetic acid to form (6R,7R)-7-[2-(2-amino-4-thiazolyl)glyoxylamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid or cefdinir.

Cefdinir is a semi-synthetic, broad-spectrum, third-generation cephalosporin antibiotic used to treat a variety of bacterial infections. It appears as a white to light yellow crystalline powder that is practically insoluble in water. The molecular formula of the compound is C14H13N5O5S2, and its molar mass is 395.41 g/mol. Its density is approximately 1.89 g/cm³, and it is insoluble in water, ethanol (95%), and diethyl ether, but slightly soluble in dilute hydrochloric acid. The compound decomposes at its melting point, which is above 180 °C. The boiling point of the compound is around 708.82 °C. It is classified as a BCS Class IV drug, indicating low solubility and low permeability, and it has a pKa value of 9.7 at 25 °C. The compound carries a GHS hazard classification of "Danger" due to its potential to cause allergic skin reactions and allergy or asthma symptoms if inhaled. It is recommended to wear protective clothing and avoid breathing dust or mist while handling the compound. The compound is sold under the brand name Omnicef and is commonly available as capsules and oral suspension formulations for the treatment of respiratory tract infections.